spacer
home > pmps > winter 2001 > preventive medicine - why the pharmaceutical industry needs to invest in prevention and cure to ensure effective brande protection
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Preventive Medicine - Why the Pharmaceutical Industry Needs to Invest in Prevention and Cure to Ensure Effective Brande Protection

Historically, pharmaceutical companies have tended to adopt a pragmatically conservative approach to problems of brand infringement and counterfeiting. Whilst they are ready to act whenever threats to public safety arise, they are understandably reluctant to publicise such incidents for fear of adverse effects on consumer confidence and share prices. However, a reactive approach to brand protection is becoming increasingly untenable - the changing value and role of pharmaceutical brands and the globalisation of the market present issues that demand a more comprehensive protection strategy.

New Market Trends - New Risks

A number of emerging trends in the pharmaceutical industry have serious implications for manufacturers and the ways in which they protect themselves, their products and, ultimately, their profits.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Keith Widdowson of De La Rue Brand Protection - Pharmaceuticals
Keith Widdowson has worked in the pharmaceutical industry for nearly 20 years, in some of the largest pharma companies such as AstraZeneca and Novartis. He has recently been responsible for ensuring that major brands are truly global and he has applied key branding elements to all commercial and manufacturing components.

spacer
Keith Widdowson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals and Nordic Nanovector have extended partnership for Betalutin® late stage manufacturing for B-cell non-Hodgkin lymphoma (NHL) treatment

The non-Hodgkin lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system
More info >>

White Papers

The Process of Informed Consent (written by ACRP)

CenterWatch

Every investigator and clinical research coordinator (CRC) should recognize the importance of obtaining valid and appropriate informed consent as an important protection of the rights and welfare of human subjects. The purpose of this ACRP guidance document is not to provide a literature review or summarize the recommendations of various working groups. Instead, the Association decided it would be helpful to provide short and focused guidance which describes how to best structure the informed consent process in accordance with best practices.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement